InGeNA is a single voice for Australian industry partners contributing to the rapidly developing field of genomics.
Alliance partners share a vision for Australia’s leadership in the adoption of genomics in healthcare.
– Better health outcomes
– Healthcare value and affordability
– A trusted, equitable and ethical genomics ecosystem
Collaboration across the key sectors of diagnostics/pathology, tech and pharma will ensure long and far-reaching benefits for Australian health consumers.
InGeNA the industry voice for the future of genomics in Australia
Acute care genomics: Rapid rare disease diagnosis on a national scale
Wednesday 13 July 2022 | 12:30pm – 1:30pm AEST | Online via Zoom
This study considered rapid genomic testing for critically ill children with suspected genetic conditions. Professor Zornitza Stark, a lead investigator on the project, will discuss the program’s effectiveness and the health economic impact. Kirsten Boggs will then talk about the same program from her perspective as a genetic counsellor, discussing the effect that the program has on the families involved.
Who we are
InGeNA was formed by a group of industry organisations, hosted by the Australasian Institute of Digital Health (AIDH), to bring a shared perspective on critically important areas underpinning the future of genomics.
- A patient-centred approach
- Digital infrastructure & principles
- Workforce planning & skills
- Government policy making
VISION Realising the full potential of genomics to personalise healthcare
MISSION To harness the collective skills and expertise of industry to integrate genomics into healthcare
Stay connected, stay informed! We welcome your interest. Complete this form to sign up for regular news, events and updates.
“We want Australians to have equity and access to the best that genomics can offer, now and in the future. With industry collaboration through InGeNA, there will be a single voice to have input into strategic planning, governance and funding directions through government, research centres and consumer health.”
To elevate the capabilities of the various workforces servicing the Australian genomics sector, InGeNA the industry voice for the future of genomics in Australia, has released a new competency framework to address workforce competency gaps in precision medicine. The...
The recent InGeNA strategic planning day was a great success with a range of initiatives discussed and planned for 2022. Held in late February the key focus areas discussed for 2022/23 included: building a national network of members, partners, and collaborators...
The first InGeNA quarterly forum for the year will be held of 17 March 2022. The online event is open to employees of InGeNA member companies, as well as select groups and government agencies offered an invite to present and attend. The purpose of each quarterly forum...
The promise of genomics is to help Australians live longer and healthier lives by integrating genomics into the management of health and integrating genomics information and workflows into the health system.
The current focus of genomics is on using individual genetic information to inform tailored healthcare decisions.
Genomics is also expected to have a large impact at the population level in the future. Genomics has the potential to enable earlier diagnosis, improve the identification of the best treatment for the patient, and assist in disease prevention by analysing many genes or the entire genome (comprising all 22,000 genes present in human DNA) at once.
A collection of useful references and sources from across Australia’s genomics ecosystem.
- [email protected]
+61 3 9326 3311
Level 1, 85 Buckhurst Street,
South Melbourne VIC 3205, Australia